Peripheral T cell expansion predicts tumour infiltration and clinical response.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
03 2020
Historique:
received: 27 09 2018
accepted: 08 01 2020
pubmed: 28 2 2020
medline: 21 3 2020
entrez: 28 2 2020
Statut: ppublish

Résumé

Despite the resounding clinical success in cancer treatment of antibodies that block the interaction of PD1 with its ligand PDL1

Identifiants

pubmed: 32103181
doi: 10.1038/s41586-020-2056-8
pii: 10.1038/s41586-020-2056-8
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
Antineoplastic Agents 0
Receptors, Antigen, T-Cell 0
atezolizumab 52CMI0WC3Y

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-278

Références

Mellman, I., Coukos, G. & Dranoff, G. Cancer immunotherapy comes of age. Nature 480, 480–489 (2011).
pubmed: 22193102 pmcid: 3967235 doi: 10.1038/nature10673
Shulman, Z. et al. Transendothelial migration of lymphocytes mediated by intraendothelial vesicle stores rather than by extracellular chemokine depots. Nat. Immunol. 13, 67–76 (2012).
doi: 10.1038/ni.2173
Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med. 24, 978–985 (2018).
doi: 10.1038/s41591-018-0045-3 pubmed: 29942094
Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268–272 (2018).
doi: 10.1038/s41586-018-0694-x pubmed: 30479382
Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251–1259 (2019).
pubmed: 31359002 pmcid: 6689255 doi: 10.1038/s41591-019-0522-3
Schenkel, J. M. & Masopust, D. Tissue-resident memory T cells. Immunity 41, 886–897 (2014).
pubmed: 25526304 pmcid: 4276131 doi: 10.1016/j.immuni.2014.12.007
Mackay, L. K. et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459–463 (2016).
pubmed: 27102484 doi: 10.1126/science.aad2035
Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 20, 2921–2934 (2017).
pubmed: 28930685 pmcid: 5646692 doi: 10.1016/j.celrep.2017.08.078
Im, S. J. et al. Defining CD8
pubmed: 27501248 pmcid: 5297183 doi: 10.1038/nature19330
Miller, B. C. et al. Subsets of exhausted CD8
pubmed: 30778252 pmcid: 6673650 doi: 10.1038/s41590-019-0312-6
Balin, S. J. et al. Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria. Sci. Immunol. 3, eaat7668 (2018).
pubmed: 30171080 pmcid: 6431239 doi: 10.1126/sciimmunol.aat7668
Thommen, D. S. et al. A transcriptionally and functionally distinct PD
pubmed: 29892065 pmcid: 6110381 doi: 10.1038/s41591-018-0057-z
Sun, Q., Hao, Q. & Prasanth, K. V. Nuclear long noncoding RNAs: key regulators of gene expression. Trends Genet. 34, 142–157 (2018).
pubmed: 29249332 pmcid: 6002860 doi: 10.1016/j.tig.2017.11.005
Delmas, V., Stokes, D. G. & Perry, R. P. A mammalian DNA-binding protein that contains a chromodomain and an SNF2/SWI2-like helicase domain. Proc. Natl Acad. Sci. USA 90, 2414–2418 (1993).
pubmed: 8460153 doi: 10.1073/pnas.90.6.2414 pmcid: 46097
Gaide, O. et al. Common clonal origin of central and resident memory T cells following skin immunization. Nat. Med. 21, 647–653 (2015).
pubmed: 25962122 pmcid: 4632197 doi: 10.1038/nm.3860
Simoni, Y. et al. Bystander CD8
pubmed: 29769722 doi: 10.1038/s41586-018-0130-2
Scheper, W. et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat. Med. 25, 89–94 (2019).
pubmed: 30510250 doi: 10.1038/s41591-018-0266-5
Mariathasan, S. et al. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554, 544–548 (2018).
pubmed: 29443960 pmcid: 6028240 doi: 10.1038/nature25501
Fehrenbacher, L. et al. Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial. Lancet 387, 1837–1846 (2016).
pubmed: 26970723 doi: 10.1016/S0140-6736(16)00587-0
McDermott, D. F. et al. Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nat. Med. 24, 749–757 (2018).
pubmed: 29867230 pmcid: 6721896 doi: 10.1038/s41591-018-0053-3
Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014).
pubmed: 25428505 pmcid: 4246418 doi: 10.1038/nature13954
Araujo, J. M. et al. Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer. Sci. Rep. 8, 4899 (2018).
pubmed: 29559701 pmcid: 5861063 doi: 10.1038/s41598-018-23099-7
Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321–330 (2017).
pubmed: 28102259 doi: 10.1038/nature21349
Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486–499 (2015).
pubmed: 26205583 pmcid: 4889009 doi: 10.1038/nri3862
Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27, 450–461 (2015).
pubmed: 25858804 pmcid: 4400238 doi: 10.1016/j.ccell.2015.03.001
Khan, O. et al. TOX transcriptionally and epigenetically programs CD8
pubmed: 31207603 pmcid: 6713202 doi: 10.1038/s41586-019-1325-x
Scott, A. C. et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature 571, 270–274 (2019).
pubmed: 31207604 doi: 10.1038/s41586-019-1324-y pmcid: 7698992
Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998–1013 (2018).
pubmed: 30388456 pmcid: 6641984 doi: 10.1016/j.cell.2018.10.038
Yan, Y. et al. CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy. JCI Insight 3, e97828 (2018).
pmcid: 5931117 doi: 10.1172/jci.insight.97828
Schumacher, T. N. & Scheper, W. A liquid biopsy for cancer immunotherapy. Nat. Med. 22, 340–341 (2016).
pubmed: 27050586 doi: 10.1038/nm.4074
Hogan, S. A. et al. Peripheral blood TCR repertoire profiling may facilitate patient stratification for immunotherapy against melanoma. Cancer Immunol. Res. 7, 77–85 (2019).
pubmed: 30425105 doi: 10.1158/2326-6066.CIR-18-0136
Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).
pubmed: 28091601 pmcid: 5241818 doi: 10.1038/ncomms14049
Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888–1902 (2019).
doi: 10.1016/j.cell.2019.05.031 pubmed: 31178118 pmcid: 6687398
Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163–172 (2019).
pubmed: 30643263 pmcid: 6340744 doi: 10.1038/s41590-018-0276-y
Del Carratore, F. et al. RankProd 2.0: a refactored bioconductor package for detecting differentially expressed features in molecular profiling datasets. Bioinformatics 33, 2774–2775 (2017).
pubmed: 28481966 pmcid: 5860065 doi: 10.1093/bioinformatics/btx292
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 4402510 doi: 10.1093/nar/gkv007
Diedenhofen, B. & Musch, J. cocor: a comprehensive solution for the statistical comparison of correlations. PLoS One 10, e0121945 (2015).
pubmed: 25835001 pmcid: 4383486 doi: 10.1371/journal.pone.0121945
Chao, A. et al. Rarefaction and extrapolation with Hill numbers: a framework for sampling and estimation in species diversity studies. Ecol. Monogr. 84, 45–67 (2014).
doi: 10.1890/13-0133.1
Therneau, T. M. & Grambsch, P. M. Modeling Survival Data: Extending the Cox Model (Springer, 2000).
McInnes, L. & Healy, J. UMAP: uniform manifold approximation and projection for dimension reduction. Preprint at https://arXiv.org/abs/1802.03426 (2018).
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. 37, 38–44 (2019).
doi: 10.1038/nbt.4314
Zeileis, A. et al. colorspace: a toolbox for manipulating and assessing colors and palettes. Preprint at https://arXiv.org/abs/1903.06490 (2019).
Barter, R. L. & Yu, B. Superheat: an R package for creating beautiful and extendable heatmaps for visualizing complex data. J. Comput. Graph. Stat. 27, 910–922 (2018).
pubmed: 30911216 pmcid: 6430237 doi: 10.1080/10618600.2018.1473780
Morgan, M. T. & Davis, S. R. GenomicDataCommons: a bioconductor interface to the NCI Genomic Data Commons. Preprint at https://www.bioRxiv.org/content/10.1101/117200v1 (2017).
Davis, S. & Meltzer, P. S. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 23, 1846–1847 (2007).
pubmed: 17496320 doi: 10.1093/bioinformatics/btm254
Shimizu, Y., Meunier, L. & Hendershot, L. M. pERp1 is significantly up-regulated during plasma cell differentiation and contributes to the oxidative folding of immunoglobulin. Proc. Natl Acad. Sci. USA 106, 17013–17018 (2009).
pubmed: 19805157 doi: 10.1073/pnas.0811591106 pmcid: 2761359
Andreani, V. et al. Cochaperone Mzb1 is a key effector of Blimp1 in plasma cell differentiation and β1-integrin function. Proc. Natl Acad. Sci. USA 115, E9630–E9639 (2018).
pubmed: 30257949 doi: 10.1073/pnas.1809739115 pmcid: 6187189
Beham, A. W. et al. A TNF-regulated recombinatorial macrophage immune receptor implicated in granuloma formation in tuberculosis. PLoS Pathog. 7, e1002375 (2011).
pubmed: 22114556 pmcid: 3219713 doi: 10.1371/journal.ppat.1002375
Fuchs, T. et al. Expression of combinatorial immunoglobulins in macrophages in the tumor microenvironment. PLoS One 13, e0204108 (2018).
pubmed: 30240437 pmcid: 6150476 doi: 10.1371/journal.pone.0204108
Thul, P. J. et al. A subcellular map of the human proteome. Science 356, 820 (2017).
doi: 10.1126/science.aal3321
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
doi: 10.1073/pnas.0506580102 pubmed: 16199517 pmcid: 1239896
Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739–1740 (2011).
pubmed: 21546393 pmcid: 3106198 doi: 10.1093/bioinformatics/btr260
Irizarry, R. A., Wang, C., Zhou, Y. & Speed, T. P. Gene set enrichment analysis made simple. Stat. Methods Med. Res. 18, 565–575 (2009).
pubmed: 20048385 pmcid: 3134237 doi: 10.1177/0962280209351908
Shugay, M. et al. VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res. 46, D419–D427 (2018).
pubmed: 28977646 doi: 10.1093/nar/gkx760
Li, B. et al. Landscape of tumor-infiltrating T cell repertoire of human cancers. Nat. Genet. 48, 725–732 (2016).
pubmed: 27240091 pmcid: 5298896 doi: 10.1038/ng.3581
Shan, G. & Gerstenberger, S. Fisher’s exact approach for post hoc analysis of a chi-squared test. PLoS One 12, e0188709 (2017).
pubmed: 29261690 pmcid: 5737889 doi: 10.1371/journal.pone.0188709

Auteurs

Thomas D Wu (TD)

Department of Bioinformatics and Computational Biology, Genentech, Inc., South San Francisco, CA, USA. twu@gene.com.

Shravan Madireddi (S)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Patricia E de Almeida (PE)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Romain Banchereau (R)

Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.

Ying-Jiun J Chen (YJ)

Department of Microchemistry, Proteomics, Lipidomics and Next Generation Sequencing, Genentech, Inc., South San Francisco, CA, USA.

Avantika S Chitre (AS)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Eugene Y Chiang (EY)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Hina Iftikhar (H)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

William E O'Gorman (WE)

Department of OMNI Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.

Amelia Au-Yeung (A)

Department of OMNI Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.

Chikara Takahashi (C)

Department of OMNI Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.

Leonard D Goldstein (LD)

Department of Bioinformatics and Computational Biology, Genentech, Inc., South San Francisco, CA, USA.

Chungkee Poon (C)

Department of Research Biology, Genentech, Inc., South San Francisco, CA, USA.

Shilpa Keerthivasan (S)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Denise E de Almeida Nagata (DE)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Xiangnan Du (X)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Hyang-Mi Lee (HM)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Karl L Banta (KL)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Sanjeev Mariathasan (S)

Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.

Meghna Das Thakur (M)

Department of Development Sciences, Genentech, Inc., South San Francisco, CA, USA.

Mahrukh A Huseni (MA)

Department of Development Sciences, Genentech, Inc., South San Francisco, CA, USA.

Marcus Ballinger (M)

Department of Development Sciences, Genentech, Inc., South San Francisco, CA, USA.

Ivette Estay (I)

Department of Development Sciences, Genentech, Inc., South San Francisco, CA, USA.

Patrick Caplazi (P)

Department of Pathology, Genentech, Inc., South San Francisco, CA, USA.

Zora Modrusan (Z)

Department of Microchemistry, Proteomics, Lipidomics and Next Generation Sequencing, Genentech, Inc., South San Francisco, CA, USA.

Lélia Delamarre (L)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Ira Mellman (I)

Department of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.

Richard Bourgon (R)

Department of Bioinformatics and Computational Biology, Genentech, Inc., South San Francisco, CA, USA.

Jane L Grogan (JL)

ArsenalBio, South San Francisco, CA, USA. jane@arsenalbio.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH